APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Live Attenuated Rotavirus Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Oral Live Attenuated Rotavirus Vaccine Market Analysis and Forecast 2026-2032

29 December 2025192 pages

Choose your research edition.

Industry ResearchOral Live Attenuated Rotavirus Vaccine Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Live Attenuated Rotavirus Vaccine Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Oral Live Attenuated Rotavirus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Live Attenuated Rotavirus Vaccine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Live Attenuated Rotavirus Vaccine Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Oral Live Attenuated Rotavirus Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Oral Live Attenuated Rotavirus Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Oral Live Attenuated Rotavirus Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Oral Live Attenuated Rotavirus Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Oral Live Attenuated Rotavirus Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Oral Live Attenuated Rotavirus Vaccine include Merck Sharp & Dohme, Lanzhou Biological Products Research Institute, GSK and Bharat Biotech, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Oral Live Attenuated Rotavirus Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Oral Live Attenuated Rotavirus Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Oral Live Attenuated Rotavirus Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oral Live Attenuated Rotavirus Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Oral Live Attenuated Rotavirus Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Oral Live Attenuated Rotavirus Vaccine sales, projected growth trends, production technology, application and end-user industry.

Oral Live Attenuated Rotavirus Vaccine Segment by Company

Merck Sharp & Dohme

Lanzhou Biological Products Research Institute

GSK

Bharat Biotech

Oral Live Attenuated Rotavirus Vaccine Segment by Type

Monovalent Vaccines

Combination Vaccines

Oral Live Attenuated Rotavirus Vaccine Segment by Application

Hospitals and Clinics

Vaccination Sites

Oral Live Attenuated Rotavirus Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Live Attenuated Rotavirus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Live Attenuated Rotavirus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Live Attenuated Rotavirus Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Oral Live Attenuated Rotavirus Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Oral Live Attenuated Rotavirus Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Live Attenuated Rotavirus Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oral Live Attenuated Rotavirus Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Monovalent Vaccines Major Manufacturers Table 3. Combination Vaccines Major Manufacturers Table 4. Global Oral Live Attenuated Rotavirus Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals and Clinics Major Manufacturers Table 6. Vaccination Sites Major Manufacturers Table 7. Oral Live Attenuated Rotavirus Vaccine Industry Trends Table 8. Oral Live Attenuated Rotavirus Vaccine Industry Drivers Table 9. Oral Live Attenuated Rotavirus Vaccine Industry Opportunities and Challenges Table 10. Oral Live Attenuated Rotavirus Vaccine Industry Restraints Table 11. Global Oral Live Attenuated Rotavirus Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Region (2021-2026) Table 15. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Region (2027-2032) Table 16. Global Oral Live Attenuated Rotavirus Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Oral Live Attenuated Rotavirus Vaccine Sales by Region (2021-2026) & (K Units) Table 18. Global Oral Live Attenuated Rotavirus Vaccine Sales by Region (2027-2032) & (K Units) Table 19. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Region (2021-2026) Table 20. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Region (2027-2032) Table 21. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Oral Live Attenuated Rotavirus Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Manufacturers (2021-2026) Table 25. Global Oral Live Attenuated Rotavirus Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Oral Live Attenuated Rotavirus Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Oral Live Attenuated Rotavirus Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Oral Live Attenuated Rotavirus Vaccine Manufacturers, Product Type & Application Table 29. Global Oral Live Attenuated Rotavirus Vaccine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Oral Live Attenuated Rotavirus Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2021-2026) Table 36. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2027-2032) Table 37. Global Oral Live Attenuated Rotavirus Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 39. Global Oral Live Attenuated Rotavirus Vaccine Sales by Type (2027-2032) & (K Units) Table 40. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2021-2026) Table 41. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2027-2032) Table 42. Global Oral Live Attenuated Rotavirus Vaccine Price by Type (2021-2026) & (US$/Unit) Table 43. Global Oral Live Attenuated Rotavirus Vaccine Price by Type (2027-2032) & (US$/Unit) Table 44. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Application (2021-2026) Table 48. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Application (2027-2032) Table 49. Global Oral Live Attenuated Rotavirus Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 51. Global Oral Live Attenuated Rotavirus Vaccine Sales by Application (2027-2032) & (K Units) Table 52. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2021-2026) Table 53. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2027-2032) Table 54. Global Oral Live Attenuated Rotavirus Vaccine Price by Application (2021-2026) & (US$/Unit) Table 55. Global Oral Live Attenuated Rotavirus Vaccine Price by Application (2027-2032) & (US$/Unit) Table 56. Merck Sharp & Dohme Company Information Table 57. Merck Sharp & Dohme Business Overview Table 58. Merck Sharp & Dohme Oral Live Attenuated Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Merck Sharp & Dohme Oral Live Attenuated Rotavirus Vaccine Product Portfolio Table 60. Merck Sharp & Dohme Recent Development Table 61. Lanzhou Biological Products Research Institute Company Information Table 62. Lanzhou Biological Products Research Institute Business Overview Table 63. Lanzhou Biological Products Research Institute Oral Live Attenuated Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Lanzhou Biological Products Research Institute Oral Live Attenuated Rotavirus Vaccine Product Portfolio Table 65. Lanzhou Biological Products Research Institute Recent Development Table 66. GSK Company Information Table 67. GSK Business Overview Table 68. GSK Oral Live Attenuated Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. GSK Oral Live Attenuated Rotavirus Vaccine Product Portfolio Table 70. GSK Recent Development Table 71. Bharat Biotech Company Information Table 72. Bharat Biotech Business Overview Table 73. Bharat Biotech Oral Live Attenuated Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Bharat Biotech Oral Live Attenuated Rotavirus Vaccine Product Portfolio Table 75. Bharat Biotech Recent Development Table 76. North America Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 77. North America Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 78. North America Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 79. North America Oral Live Attenuated Rotavirus Vaccine Sales by Type (2027-2032) & (K Units) Table 80. North America Oral Live Attenuated Rotavirus Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 81. North America Oral Live Attenuated Rotavirus Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 82. North America Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 83. North America Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 84. North America Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 85. North America Oral Live Attenuated Rotavirus Vaccine Sales by Application (2027-2032) & (K Units) Table 86. North America Oral Live Attenuated Rotavirus Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 87. North America Oral Live Attenuated Rotavirus Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 88. North America Oral Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. North America Oral Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 90. North America Oral Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 91. North America Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 92. North America Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 93. North America Oral Live Attenuated Rotavirus Vaccine Sales by Country (2027-2032) & (K Units) Table 94. North America Oral Live Attenuated Rotavirus Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 95. North America Oral Live Attenuated Rotavirus Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 96. United States Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 97. Canada Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 98. Mexico Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 99. Europe Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 100. Europe Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 101. Europe Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 102. Europe Oral Live Attenuated Rotavirus Vaccine Sales by Type (2027-2032) & (K Units) Table 103. Europe Oral Live Attenuated Rotavirus Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 104. Europe Oral Live Attenuated Rotavirus Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 105. Europe Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 108. Europe Oral Live Attenuated Rotavirus Vaccine Sales by Application (2027-2032) & (K Units) Table 109. Europe Oral Live Attenuated Rotavirus Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 110. Europe Oral Live Attenuated Rotavirus Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 111. Europe Oral Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Europe Oral Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 113. Europe Oral Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 114. Europe Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 115. Europe Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 116. Europe Oral Live Attenuated Rotavirus Vaccine Sales by Country (2027-2032) & (K Units) Table 117. Europe Oral Live Attenuated Rotavirus Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 118. Europe Oral Live Attenuated Rotavirus Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 119. Germany Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 120. France Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 121. U.K. Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 122. Italy Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 123. Russia Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 124. Spain Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 125. Netherlands Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 126. Switzerland Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 127. Sweden Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 128. Poland Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 129. China Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 130. China Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 131. China Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 132. China Oral Live Attenuated Rotavirus Vaccine Sales by Type (2027-2032) & (K Units) Table 133. China Oral Live Attenuated Rotavirus Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 134. China Oral Live Attenuated Rotavirus Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 135. China Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 136. China Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 137. China Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 138. China Oral Live Attenuated Rotavirus Vaccine Sales by Application (2027-2032) & (K Units) Table 139. China Oral Live Attenuated Rotavirus Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 140. China Oral Live Attenuated Rotavirus Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 141. Asia Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 142. Asia Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 143. Asia Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 144. Asia Oral Live Attenuated Rotavirus Vaccine Sales by Type (2027-2032) & (K Units) Table 145. Asia Oral Live Attenuated Rotavirus Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 146. Asia Oral Live Attenuated Rotavirus Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 147. Asia Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 148. Asia Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 149. Asia Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 150. Asia Oral Live Attenuated Rotavirus Vaccine Sales by Application (2027-2032) & (K Units) Table 151. Asia Oral Live Attenuated Rotavirus Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 152. Asia Oral Live Attenuated Rotavirus Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 153. Asia Oral Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Asia Oral Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 155. Asia Oral Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 156. Asia Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 157. Asia Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 158. Asia Oral Live Attenuated Rotavirus Vaccine Sales by Country (2027-2032) & (K Units) Table 159. Asia Oral Live Attenuated Rotavirus Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 160. Asia Oral Live Attenuated Rotavirus Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 161. Japan Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 162. South Korea Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 163. India Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 164. Australia Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 165. Taiwan Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 166. Southeast Asia Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 167. SAMEA Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 168. SAMEA Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 169. SAMEA Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 170. SAMEA Oral Live Attenuated Rotavirus Vaccine Sales by Type (2027-2032) & (K Units) Table 171. SAMEA Oral Live Attenuated Rotavirus Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 172. SAMEA Oral Live Attenuated Rotavirus Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 173. SAMEA Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 174. SAMEA Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 175. SAMEA Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 176. SAMEA Oral Live Attenuated Rotavirus Vaccine Sales by Application (2027-2032) & (K Units) Table 177. SAMEA Oral Live Attenuated Rotavirus Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 178. SAMEA Oral Live Attenuated Rotavirus Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 179. SAMEA Oral Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 180. SAMEA Oral Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 181. SAMEA Oral Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 182. SAMEA Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 183. SAMEA Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 184. SAMEA Oral Live Attenuated Rotavirus Vaccine Sales by Country (2027-2032) & (K Units) Table 185. SAMEA Oral Live Attenuated Rotavirus Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 186. SAMEA Oral Live Attenuated Rotavirus Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 187. Brazil Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 188. Argentina Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 189. Chile Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 190. Colombia Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 191. Peru Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 192. Saudi Arabia Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 193. Israel Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 194. UAE Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 195. Turkey Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 196. Iran Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 197. Egypt Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Table 198. Key Raw Materials Table 199. Raw Materials Key Suppliers Table 200. Oral Live Attenuated Rotavirus Vaccine Distributors List Table 201. Oral Live Attenuated Rotavirus Vaccine Customers List Table 202. Research Programs/Design for This Report Table 203. Authors List of This Report Table 204. Secondary Sources Table 205. Primary Sources List of Figures Figure 1. Oral Live Attenuated Rotavirus Vaccine Image Figure 2. Global Oral Live Attenuated Rotavirus Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Live Attenuated Rotavirus Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Monovalent Vaccines Image Figure 5. Combination Vaccines Image Figure 6. Global Oral Live Attenuated Rotavirus Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Oral Live Attenuated Rotavirus Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals and Clinics Image Figure 9. Vaccination Sites Image Figure 10. Global Oral Live Attenuated Rotavirus Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Oral Live Attenuated Rotavirus Vaccine Revenue (2021-2032) & (US$ Million) Figure 12. Global Oral Live Attenuated Rotavirus Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Region (2021-2032) Figure 15. Global Oral Live Attenuated Rotavirus Vaccine Sales (2021-2032) & (K Units) Figure 16. Global Oral Live Attenuated Rotavirus Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Oral Live Attenuated Rotavirus Vaccine Sales YoY (2021-2032) & (K Units) Figure 19. Europe Oral Live Attenuated Rotavirus Vaccine Sales YoY (2021-2032) & (K Units) Figure 20. China Oral Live Attenuated Rotavirus Vaccine Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Oral Live Attenuated Rotavirus Vaccine Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Oral Live Attenuated Rotavirus Vaccine Sales YoY (2021-2032) & (K Units) Figure 23. Global Oral Live Attenuated Rotavirus Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Oral Live Attenuated Rotavirus Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2021-2032) Figure 29. Global Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2021-2032) Figure 32. Global Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Application (2021-2032) Figure 35. Global Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2021-2032) Figure 38. North America Oral Live Attenuated Rotavirus Vaccine Revenue Share by Type (2021-2032) Figure 39. North America Oral Live Attenuated Rotavirus Vaccine Sales Share by Type (2021-2032) Figure 40. North America Oral Live Attenuated Rotavirus Vaccine Revenue Share by Application (2021-2032) Figure 41. North America Oral Live Attenuated Rotavirus Vaccine Sales Share by Application (2021-2032) Figure 42. North America Oral Live Attenuated Rotavirus Vaccine Revenue Share by Country (2021-2032) Figure 43. North America Oral Live Attenuated Rotavirus Vaccine Sales Share by Country (2021-2032) Figure 44. Europe Oral Live Attenuated Rotavirus Vaccine Revenue Share by Type (2021-2032) Figure 45. Europe Oral Live Attenuated Rotavirus Vaccine Sales Share by Type (2021-2032) Figure 46. Europe Oral Live Attenuated Rotavirus Vaccine Revenue Share by Application (2021-2032) Figure 47. Europe Oral Live Attenuated Rotavirus Vaccine Sales Share by Application (2021-2032) Figure 48. Europe Oral Live Attenuated Rotavirus Vaccine Revenue Share by Country (2021-2032) Figure 49. Europe Oral Live Attenuated Rotavirus Vaccine Sales Share by Country (2021-2032) Figure 50. China Oral Live Attenuated Rotavirus Vaccine Revenue Share by Type (2021-2032) Figure 51. China Oral Live Attenuated Rotavirus Vaccine Sales Share by Type (2021-2032) Figure 52. China Oral Live Attenuated Rotavirus Vaccine Revenue Share by Application (2021-2032) Figure 53. China Oral Live Attenuated Rotavirus Vaccine Sales Share by Application (2021-2032) Figure 54. Asia Oral Live Attenuated Rotavirus Vaccine Revenue Share by Type (2021-2032) Figure 55. Asia Oral Live Attenuated Rotavirus Vaccine Sales Share by Type (2021-2032) Figure 56. Asia Oral Live Attenuated Rotavirus Vaccine Revenue Share by Application (2021-2032) Figure 57. Asia Oral Live Attenuated Rotavirus Vaccine Sales Share by Application (2021-2032) Figure 58. Asia Oral Live Attenuated Rotavirus Vaccine Revenue Share by Country (2021-2032) Figure 59. Asia Oral Live Attenuated Rotavirus Vaccine Sales Share by Country (2021-2032) Figure 60. SAMEA Oral Live Attenuated Rotavirus Vaccine Revenue Share by Type (2021-2032) Figure 61. SAMEA Oral Live Attenuated Rotavirus Vaccine Sales Share by Type (2021-2032) Figure 62. SAMEA Oral Live Attenuated Rotavirus Vaccine Revenue Share by Application (2021-2032) Figure 63. SAMEA Oral Live Attenuated Rotavirus Vaccine Sales Share by Application (2021-2032) Figure 64. SAMEA Oral Live Attenuated Rotavirus Vaccine Revenue Share by Country (2021-2032) Figure 65. SAMEA Oral Live Attenuated Rotavirus Vaccine Sales Share by Country (2021-2032) Figure 66. Oral Live Attenuated Rotavirus Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Oral Live Attenuated Rotavirus Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Monovalent Vaccines
  • Combination Vaccines
Applications
  • Hospitals and Clinics
  • Vaccination Sites
Companies covered
  • Merck Sharp & Dohme
  • Lanzhou Biological Products Research Institute
  • GSK
  • Bharat Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Oral Live Attenuated Rotavirus Vaccine Market by Type
  3. 1.2.1 Global Oral Live Attenuated Rotavirus Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Monovalent Vaccines
  5. 1.2.3 Combination Vaccines
  6. 1.3 Oral Live Attenuated Rotavirus Vaccine Market by Application
  7. 1.3.1 Global Oral Live Attenuated Rotavirus Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals and Clinics
  9. 1.3.3 Vaccination Sites
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Oral Live Attenuated Rotavirus Vaccine Market Dynamics
  1. 2.1 Oral Live Attenuated Rotavirus Vaccine Industry Trends
  2. 2.2 Oral Live Attenuated Rotavirus Vaccine Industry Drivers
  3. 2.3 Oral Live Attenuated Rotavirus Vaccine Industry Opportunities and Challenges
  4. 2.4 Oral Live Attenuated Rotavirus Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Oral Live Attenuated Rotavirus Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Region
  3. 3.2.1 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Oral Live Attenuated Rotavirus Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Oral Live Attenuated Rotavirus Vaccine Sales by Region
  9. 3.4.1 Global Oral Live Attenuated Rotavirus Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Oral Live Attenuated Rotavirus Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Oral Live Attenuated Rotavirus Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Oral Live Attenuated Rotavirus Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Oral Live Attenuated Rotavirus Vaccine Sales by Manufacturers
  6. 4.2.1 Global Oral Live Attenuated Rotavirus Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Oral Live Attenuated Rotavirus Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Oral Live Attenuated Rotavirus Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Oral Live Attenuated Rotavirus Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Oral Live Attenuated Rotavirus Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Oral Live Attenuated Rotavirus Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Oral Live Attenuated Rotavirus Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Oral Live Attenuated Rotavirus Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Oral Live Attenuated Rotavirus Vaccine Tier 1, Tier 2, and Tier 3
5 Oral Live Attenuated Rotavirus Vaccine Market by Type
  1. 5.1 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Type
  2. 5.1.1 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Oral Live Attenuated Rotavirus Vaccine Sales by Type
  6. 5.2.1 Global Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Oral Live Attenuated Rotavirus Vaccine Price by Type
6 Oral Live Attenuated Rotavirus Vaccine Market by Application
  1. 6.1 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Application
  2. 6.1.1 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Oral Live Attenuated Rotavirus Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Oral Live Attenuated Rotavirus Vaccine Sales by Application
  6. 6.2.1 Global Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Oral Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Oral Live Attenuated Rotavirus Vaccine Price by Application
7 Company Profiles
  1. 7.1 Merck Sharp & Dohme
  2. 7.1.1 Merck Sharp & Dohme Company Information
  3. 7.1.2 Merck Sharp & Dohme Business Overview
  4. 7.1.3 Merck Sharp & Dohme Oral Live Attenuated Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merck Sharp & Dohme Oral Live Attenuated Rotavirus Vaccine Product Portfolio
  6. 7.1.5 Merck Sharp & Dohme Recent Developments
  7. 7.2 Lanzhou Biological Products Research Institute
  8. 7.2.1 Lanzhou Biological Products Research Institute Company Information
  9. 7.2.2 Lanzhou Biological Products Research Institute Business Overview
  10. 7.2.3 Lanzhou Biological Products Research Institute Oral Live Attenuated Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Lanzhou Biological Products Research Institute Oral Live Attenuated Rotavirus Vaccine Product Portfolio
  12. 7.2.5 Lanzhou Biological Products Research Institute Recent Developments
  13. 7.3 GSK
  14. 7.3.1 GSK Company Information
  15. 7.3.2 GSK Business Overview
  16. 7.3.3 GSK Oral Live Attenuated Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 GSK Oral Live Attenuated Rotavirus Vaccine Product Portfolio
  18. 7.3.5 GSK Recent Developments
  19. 7.4 Bharat Biotech
  20. 7.4.1 Bharat Biotech Company Information
  21. 7.4.2 Bharat Biotech Business Overview
  22. 7.4.3 Bharat Biotech Oral Live Attenuated Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Bharat Biotech Oral Live Attenuated Rotavirus Vaccine Product Portfolio
  24. 7.4.5 Bharat Biotech Recent Developments
8 North America
  1. 8.1 North America Oral Live Attenuated Rotavirus Vaccine Market Size by Type
  2. 8.1.1 North America Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Oral Live Attenuated Rotavirus Vaccine Price by Type (2021-2032)
  5. 8.2 North America Oral Live Attenuated Rotavirus Vaccine Market Size by Application
  6. 8.2.1 North America Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Oral Live Attenuated Rotavirus Vaccine Price by Application (2021-2032)
  9. 8.3 North America Oral Live Attenuated Rotavirus Vaccine Market Size by Country
  10. 8.3.1 North America Oral Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Oral Live Attenuated Rotavirus Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Oral Live Attenuated Rotavirus Vaccine Market Size by Type
  2. 9.1.1 Europe Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Oral Live Attenuated Rotavirus Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Oral Live Attenuated Rotavirus Vaccine Market Size by Application
  6. 9.2.1 Europe Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Oral Live Attenuated Rotavirus Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Oral Live Attenuated Rotavirus Vaccine Market Size by Country
  10. 9.3.1 Europe Oral Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Oral Live Attenuated Rotavirus Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Oral Live Attenuated Rotavirus Vaccine Market Size by Type
  2. 10.1.1 China Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Oral Live Attenuated Rotavirus Vaccine Price by Type (2021-2032)
  5. 10.2 China Oral Live Attenuated Rotavirus Vaccine Market Size by Application
  6. 10.2.1 China Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Oral Live Attenuated Rotavirus Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Oral Live Attenuated Rotavirus Vaccine Market Size by Type
  2. 11.1.1 Asia Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Oral Live Attenuated Rotavirus Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Oral Live Attenuated Rotavirus Vaccine Market Size by Application
  6. 11.2.1 Asia Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Oral Live Attenuated Rotavirus Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Oral Live Attenuated Rotavirus Vaccine Market Size by Country
  10. 11.3.1 Asia Oral Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Oral Live Attenuated Rotavirus Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Oral Live Attenuated Rotavirus Vaccine Market Size by Type
  2. 12.1.1 SAMEA Oral Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Oral Live Attenuated Rotavirus Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Oral Live Attenuated Rotavirus Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Oral Live Attenuated Rotavirus Vaccine Market Size by Application
  6. 12.2.1 SAMEA Oral Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Oral Live Attenuated Rotavirus Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Oral Live Attenuated Rotavirus Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Oral Live Attenuated Rotavirus Vaccine Market Size by Country
  10. 12.3.1 SAMEA Oral Live Attenuated Rotavirus Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Oral Live Attenuated Rotavirus Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Oral Live Attenuated Rotavirus Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Oral Live Attenuated Rotavirus Vaccine Value Chain Analysis
  2. 13.1.1 Oral Live Attenuated Rotavirus Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Oral Live Attenuated Rotavirus Vaccine Production Mode & Process
  6. 13.2 Oral Live Attenuated Rotavirus Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Oral Live Attenuated Rotavirus Vaccine Distributors
  9. 13.2.3 Oral Live Attenuated Rotavirus Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst